Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement ...

The phase III clinical trial enrolment for India's first one-shot dengue vaccine, DengiAll, developed by Panacea Biotec, is set to complete with 10,500 participants across 20 centers. This trial aims ...

KALA Bio completes enrollment in CHASE trial, advancing KPI-012 for treating persistent corneal epithelial defects. Topline ...

LOS ANGELES, CA / ACCESS Newswire / July 9, 2025 / HRC Fertility is proud to announce its participation in a groundbreaking ...

Jasper Therapeutics' valuation falls to $53M following drug development issues, leading to layoffs and a focus shift to ...

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

Saint Louis University’s Center for Vaccine Development is asking for 70 adult volunteers to participate a clinical trial ...

Small breed dogs—including dachshunds and French bulldogs—have a high risk of developing a herniated disk in their middle ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for completion by October.